FindTrial
Sign In

Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer

Comparison of 20-core vs 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00992615
Enrollment
Unknown
Registered
2009-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2012-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The optimal number of prostate cores extracted during a prostate biopsy performed because of a suspected prostate cancer is still debated. The present consensus is to sample 12 cores. However, recent data published in the literature brought arguments in favour of a higher number, probably 20. This would have the advantages of decreasing the false negatives and the re-biopsy rate.

Interventions

PROCEDUREprostate biopsy

prostate cores - 12 or 20

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* Patients older than 18 * Patients with a PSA value between 3 et 20 ng/ml * Obtained informed consent * Patients able to comply with the study protocol * Patients covered by a social insurance

Exclusion criteria

* None

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026